Article
Spatial profiling of CAR protein organization reveals in vivo remodeling during CAR-T therapy
2026-04-22
Abstract excerpt
Chimeric antigen receptor (CAR) T cell therapy utilizes genetically engineered patient-derived T cells to target cancer cells. Despite its clinical successes in multiple cancer types, the underlying molecular mechanisms by which molecules on CAR-T cells and surrounding cells interact with other proteins and collectively determine treatment efficacy remain elusive. Most previous studies have relied on transcriptome...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4d299b1b-4f40-5b9d-9c57-028e2e3e37a3
- DOI
- 10.64898/2026.04.20.719384
